The majority of cystic fibrosis patients produce a mutant form of CFTR (ΔF508) which has been shown to be mislocalised in both humans and mice. G480C, another clinically "severe" mutation, has also been demonstrated to be defective in its intracellular processing, but when allowed to traffic in Xenopus oocytes showed similar channel characteristics to that of wildtype CFTR. We have replicated the G480C mutation in the murine Cftr gene using the "hit and run" double recombination procedure. As expected, the G480C cystic fibrosis mouse model expresses the G480C mutant transcript at a level comparable to that of wild type Cftr. The homozygous mutant mice were fertile, had normal survival, weight, tooth colour and no evidence of caecal blockage, despite mild goblet cell hypertrophy in the intestine. Analysis of the mutant protein revealed that the majority of G480C CFTR was abnormally processed and no G480C CFTRspecific immunostaining in the apical membranes of intestinal cells was detected.
INTRODUCTION
Cystic fibrosis (CF) is a fatal autosomal recessive genetic disease characterised by abnormal epithelial ion transport. The mutated gene responsible is the cystic fibrosis transmembrane conductance regulator (CFTR) gene encoding a protein which functions among other things as an epithelial cAMPregulated Cl -ion channel 1 . Many hundreds of mutations have been described in CF patients but the most common mutation, is caused by deletion of a phenylalanine at position 508 (ΔF508) 2 . This mutation causes misfolding of the protein, incomplete glycosylation and prevents correct trafficking of the protein to the apical plasma membrane 3 .
In humans ΔF508 accounts for approximately 70% of all mutant CF alleles and is considered "severe" with respect to cystic fibrosis phenotype. Other "severe" mutations have been described and G480C is one where an amino acid substitution occurs in exon 10 of CFTR 3 . Both G480C and ΔF508 mutations show a primary defect in protein processing and trafficking, such that mutant protein is retained and degraded in the endoplasmic reticulum, resulting in a severe reduction at the plasma membrane 4;5;6 . When expressed in Xenopus oocytes (where the transport block can be overcome), the G480C protein has an apical plasma membrane Cl -channel activity identical to that of wild type CFTR 6 .
Contradictory reports exist for ΔF508 function at the apical membrane, some suggesting reduced function and others suggesting normal function [7] [8] [9] .
We created mutant mice that carry the G480C mutation by gene targeting using the "hit and run" technique 10;11 . These mice are comparable to the Cftr tm1Eur mice where the "hit and run" technique was used to introduce the ΔF508 mutation into the mouse. 12 . In both these Cftr mutant mice the only alteration in the Cftr gene is the introduced mutation, and transcription of the mutant allele does not deviate from wild type levels 13 . This is in contrast to replacement mouse models, where the gene targeting event introduces plasmid sequences into an intron and the transcription of the mutant allele is reduced 14, 15 . Thus for example, in the Cftr tm2Cam ΔF508 mice the level of Cftr mRNA is approximately 15% of wildtype levels 14 . In such mutant mice (eg. the ΔF508 Cftr tm2Cam and the G551D Cftr tm1G551D mice), it is therefore difficult to assess whether the phenotype is due to the precise mutation or principally related to a reduction in the level of the transcript.
The Cftr tm1Eur mice, where ΔF508 Cftr transcript levels are normal, possess a small, residual forskolin response in the gut 12 , not evident in the intestine of the "null" or other ΔF508 mutant mice. In the nasal tissue these ΔF508 mutant mice cannot be distinguished from littermates on the basis of their low chloride response 12 . The "null" and low level transcript ΔF508 mice die perinatally or at weaning due to intestinal blockage but do display a clear defect in their nasal bioelectrics. In this study an accurate mouse model of the G480C mutation was used to assess the phenotype of another "severe" cystic fibrosis mutation in vivo and to clarify the organ-specific consequences of a mistrafficking mutant.
RESULTS

Generation of Cftr tm2Hgu mice which carry the G480C mutation
ES cells modified at the Cftr locus to possess the G480C mutation in exon 10 by 'Hit and Run' gene targeting have been previously described 11 . 4 ES cell clones modified to possess the G480C mutation which had normal karyotypes were used for blastocystst injections. Germline transmission of the mutation was detected by genotyping agouti offspring from mating the chimaeric males to C57Bl/6 females and was observed in 2 independent clones, with all mice used in this study originating from a single transmitting chimaeric founder animal.
Homozygous G480C mutant mice are designated Cftr tm2Hgu following the Mouse Nomenclature Committee guidelines. A novel NsiI restriction enzyme site was created at the site of the G480C mutation ( Figure 1A ) and restriction enzyme digestion verified the faithful replacement of the wild type exon 10 with the mutant exon 10 (Figure 1 B, C, D). PCR amplification of exon 10 and digestion with NsiI differentiated the enzyme resistant wildtype band from the G480C containing band, which can be digested with the enzyme (Figure1E).
G480C mutant mice express the mutant allele at wild-type levels
Both male and female mice heterozygous for the G480C allele were included in the study and a range of tissues investigated. The ΔF508 mice generated by replacement gene targeting (Cftr tm2Cam ) show differences in the extent of allele bias between tissues 14 . Cftr mRNA expression was demonstrated by RT-PCR between exons 9 and 10 and was observed in all of the tissues investigated, (lung, colon, jejunum, ileum and testis). Samples were taken during the linear range of the PCR amplification as determined by real-time luminescence assay (Methods), to reduce heteroduplex formation. G480C products were distinguished from wild type by the presence of the novel NsiI restriction site polymorphism engineered adjacent to the missense change.
Densitometric quantitation of PCR products after NsiI digestion indicated approximately equal ratios of each allele in the ileum, jejunum, testis and lungs ( Figure 2 and Table 1 ), except in one lung sample which appeared to undergone degradation following digestion. These results indicate that the modified allele was expressed at the same level as the wild type allele and therefore the presence of the G480C mutation has no effect on the level of expression.
G480C CFTR is incompletely processed
Analysis of CFTR processing in isolated jejunal enterocytes of wild-type mice by Western blotting demonstrated a normal pattern of CFTR isoforms with the core-glycosylated isoform of CFTR (band B) in the ER, and the mature, fullyglycosylated isoform (band C) in the plasma membrane. Band B was identified only in the crude membrane preparation (Fig. 3 , lane 1) consisting of a mixture of ER, Golgi and plasma membranes, whereas band C was additionally detected
(and approximately two-fold enriched) in the brush border membrane vesicle preparations (BBMV) (Fig.3, lane 3 ) consisting of virtually pure apical membranes. In contrast, intestinal epithelium from homozygous G480C mice showed a normal intensity of the B-band of CFTR in the crude jejunal membrane fraction (Fig.3, lane 2) , but a strongly reduced intensity of the C-band (measured as 8% (+/-2) n=4, residual CFTR compared to wildtype as determined by dilution calibrated scanning of the bioluminescence) in the BBMV (Fig.3, lanes 2 and 4) .
This outcome clearly demonstrates that the G480C CFTR mutant protein is retained in the ER of the enterocytes in vivo and that only a very small fraction is able to escape the quality control mechanism in the ER and reach the cell surface.
Immunocytochemical detection of CFTR in the jejunum from wild-type mice using the R3195 antibody, (in keeping with previous findings 13 , showed intensive staining of the apical region of all crypts (Fig. 4A ). In addition, due to the improved sensitivity of CFTR staining in microwave-treated paraffin sections as compared to cryosections, CFTR immunoreactivity was also prominent in the brush border membrane of lower-and mid-villus cells. In contrast, CFTR expression in crypts and villi from homozygous G480C mutant mice remained below the detection level of the immunocytochemical technique (Fig. 4B ). This finding confirms the results of the Western blotting shown in Fig. 3 and is in line with the concept of a processing defect affecting the maturation of G480C-CFTR in both the crypt and villus compartments.
Phenotype of the cystic fibrosis mutant mice homozygous for the G480C 12 . In addition we saw no evidence (n=20 mice) of dramatic distention of crypts in the small intestine, blockage, nor any evidence of an abnormal coiled, worm-like caecum impacted with sticky fecal material which is described as the only obvious intestinal abnormality in the Cftr tm1Unc mice sacrificed while apparently still healthy 16 .
The Cftr tm1Unc "null" mice and Cftr tm1Eur ΔF508 "hit and run" mice display white teeth as a result of decreased enamel mineral content and increased magnesium ( 18 and H de J unpublished data). Both these strains of mice can be genotyped purely on the basis of their white tooth colour. The incisor teeth of the G480C mutant mice however were not abnormally white (data not shown).
Electrophysiological characteristics of G480C CFTR mice
The reduced chloride permeability of the epithelium due to CFTR dysfunction, causes typical abnormalities in the ion transport of different epithelia in both CF individuals and Cftr mutant mice. The G480C cystic fibrosis mice do not suffer from the intestinal blockage (the first signs of which are located in the caecum)
that is seen in mice with a complete disruption of Cftr expression, so we examined the electrophysological profile of these animals in the intestine.
In the caecum, Ussing chamber measurements revealed that the initial baseline Isc (short circuit current) was significantly (p=0.0001) reduced in the G480C homozygous mutants compared to controls (Fig 6A) . However the response to forskolin, which activates CFTR through an increase in cAMP, was not significantly different between wild type and mutant animals. Carbachol (which stimulates Ca 2+ mediated chloride transport) probably also via CFTR in the intestine, was however significantly (p=0.01) reduced compared to wildtypes.
In the jejunum ( Figure 6B ) however, the baseline Isc was not significantly different between the mutants and wildtypes, but the forskolin response was significantly (p=<0.01) different. The carbachol response, as in the caecum, was significantly reduced compared to littermates (p<0.01).
Several studies have demonstrated that in the intestine of rodents, the baseline and stimulated secretions are independent when the stimulation is made with forskolin. Naturally cAMP levels may be elevated via prostaglandin increase. These studies however show that the forskolin-and prostaglandinmediated pathways are independent in as far as normal forskolin-mediated secretion can be achieved following prostaglandin-mediated secretion 19 20;21 . In addition we can demonstrate (H.de J. unpublished results) that the basal short circuit current in the murine intestine was not affected by 10 -5 M indomethacin (a potent inhibitor of prostaglandin synthesis) and is therefore not prostaglandin/cAMP mediated. We are therefore confident that the responses generated in this study by forskolin are independent of any prostaglandinmediated baseline secretion in the jejunum and caecum.
We also examined the nasal biolelectrics of these mice ( figure 6C ) and in common with all other described CFTR mutant mice 22 , the baseline was significantly (p=<0.001) raised. The response to a low chloride gradient was significantly (p=0.0001) reduced in the G480C mutant animals, in contrast to the normal response reported in the Cftr tm1Eur ΔF508 mouse.
DISCUSSION
The mutant mice we present here mimic human CF individuals with the "severe" G480C mutation. The G480C mutant protein was detected in a pancreatic insufficient African-American CF patient 6 . Western blot analysis and immunofluorescent analysis revealed that even when overexpressed in 293T cells, no fully glycosylated nor apically localised protein was detectable. This suggested that the G480C protein was similar to the ΔF508 protein and subject to defective intracellular processing. We demonstrate that when replicated in the mouse, the G480C mutant CFTR is mislocalised and the defect in chloride ion transport characteristic of CF varies between tissues and is present in the nose and jejunum but absent from the caecum with no evidence of fatal gut blockage.
G480C mutant mice express normal levels of the mutant allele.
The "hit and run" procedure used to generate these mice results in the only genomic alteration being at the site of the mutation. It follows that the message levels of the mutant allele will be equivalent to the wild type allele. In ΔF508 / wild type heterozygous humans, mRNA of both alleles is present at an equal ratio 23 from intestinal blockage 24 . The "hit and run" (Cftr tm1Eur ) ΔF508 mutant mouse in contrast has a normal level of mutant transcript and although it displays evidence of growth retardation at weaning 12 , it does not demonstrate a phenotype of death from gut blockage. In contrast to the ΔF508 mice generated by replacement gene targeting, the Cftr tm1Eu ΔF508 'hit and run' mice and the Cftr tm2Hgu G480C 'hit and run' mice generated here both express normal levels of the mutant allele. mice with 100% survival) and this does not alter after 4 backcrosses onto the C57Bl/6J background. This is the same genetic background as that reported for the Cftr tm1Unc "null" mice with only 20% survival, and reproduced in our animal house 15 .
G480C mutant protein is mislocalised
It is probable that the normal forskolin response in the G480C mice compared to the abnormal response in Cftr tm1Eur ΔF508 mice is due to slightly more G480C (3% versus 8%) being correctly processed and reaching the apical membrane. However the results from Xenopus oocyte experiments using human CFTR mRNA, strongly suggested that this observed difference between the G480C and ΔF508 response to forskolin was consistent with a trafficking/processing defect in G480C CFTR, and an additional conductance defect in ΔF508 CFTR 6 . We doubt if this additional conductance defect is the case here as the ΔF508 "hit and run" mice have identical channel characteristics to wildtype in the gall bladder epithelia 13 .
The fact that "hit and run" ΔF508 mutant mice (Cftr tm1Eur ) display runting but no evidence of the fatal intestinal blockage presented by "null" CF mice is in contrast to ΔF508 homozygous patients, who do not have reduced incidence of meconium ileus when compared to patients with "null" mutations. One possible explanation is that the G480C and ΔF508 mouse phenotype appear to be different to "null" mice because of differences in human/mouse physiology and gut architecture, and the mouse is more sensitive to small increases in CFTR function.
Electrophysiological phenotype of the murine G480C mutant protein varies between tissues.
An unexpected finding was the organ-specific differences in CFTR related electrophysiology in the mutant mice. As discussed above we suggest that a normal cAMP-mediated chloride secretion in the caecum is due to around 8% correctly localized CFTR. This agrees with our previous work 25 , where we demonstrate, using intercrossed mutants, that a very low level of functional CFTR (5%) is sufficient to have a disproportionate effect on chloride ion transport and a major effect on phenotype (survival due to lack of intestinal obstruction).
Interestingly the caecal baseline and Ca 2+ -activated chloride response remain abnormal despite a normal forskolin response. This implies that these aspects may not be key markers of intestinal blockage and in addition, that there is a CFTR dose-response in terms of restoration of function within an organ. These are important considerations when monitoring the efficacy of therapies aimed at amelioration of the phenotypes in CF individuals.
In the nose of the Cftr tm2Hgu mice, in common with all other reported CF mice and individuals 22 , the baseline PD is raised indicating a defect in sodium absorption. The familiar defect in cAMP mediated chloride secretion was also observed in the nose, which is in direct contrast to the Cftr tm1Eur ΔF508 mutant mouse but in common with all other mutant mice including the 10% residual function mouse (Cftr tm1Hgu ). So, the fact that the cAMP stimulated response is not defective in the caecum, but the nasal low chloride response is defective, again demonstrates inter organ differences in this "dose response". This must reflect either tissue specific alterations in the level of mature G480C CFTR with organspecific subtle translational/post translational differences, or compensatory pathways altering the bioelectric phenotype. We tentatively suggest that correction may be more difficult in the airways as compared to the large intestine.
The Cftr tm2Hgu G480C mutant mouse is a valuable tool for therapy testing
Both the defects in sodium absorption and in chloride secretion are evident in the nose of the G480C mutant mouse and this is widely held to be the mouse tissue that mimics the human respiratory tract phenotype most closely 26 .
70% of CF chromosomes have the ΔF508 mutation and so the vast majority of CF individuals possess at least one ΔF508 allele. This makes pharmacological strategies aimed at improving the function of the ΔF508 mutant CFTR highly relevant. The three mouse models generated to date that express the ΔF508 mutant allele either suffer a high level of intestinal blockage and death (Cftr tm2Cam , Cftr tm1Kth ), or survive well but do not have the bioelectric defect of chloride ion transport in the respiratory tract. The fact that this G480C mutant mouse combines a mistrafficked CFTR mutation (similar to the ΔF508 CFTR) with normal survival means that it is an excellent in vivo model for testing drugs aimed at mutant CFTR relocation strategies.
In conclusion, the introduction of the G480C mutation into the mouse Cftr gene, using the "hit and run" technique mimics the human allele with normal levels of Cftr mRNA production. This has allowed us to demonstrate that the majority of the G480C mutant protein is mislocalised, but a low level of mature CFTR is detectable by immunoblot. The phenotype of the mutant animals is extremely mild, and does not include severe gut blockage or growth retardation.
The G480C homozygous mutant protein has different ion transport effects in different organs with pronounced effects on the baseline in the nose and the caecum. In the nose, the mutant animals have increased absorption whilst in the caecum reduced secretion is evident. Reduced stimulated chloride secretion has been found in the nose and the jejunum but a normal response was found in the caecum and this is most likely responsible for the lack of fatal intestinal blockage and normal weight of the G480C mutant mice.
MATERIALS AND METHODS
Gene Targeting in ES cells
Targeting methodology is as previously described 11 . Screening of litters for transmission of the G480C allele was performed by PCR using 25 base pair primers used to amplify exon 10 from positions 1530-1720 in the Cftr gene previously described 27 followed by NsiI digestion. µg/ml aprotinine, 5 µg/ml leupeptine, 1 µg/ml pepstatin A, 1 µg/ml chymostatin, 50 µg/ml soybean trypsin inhibitor, and 0.03 g/l phosphoramidon. Vesiculation of intestinal membranes was achieved by a freeze-thaw procedure described initially for rat enterocytes 27 and crude microsomal membranes were isolated from half of the cell lysate by a two-step differential centrifugation procedure (10 min, 4.000g, followed by 60 min, 40.000 g). The other half was used to isolate brush border membrane vesicles (BBMV) by differential precipitation with 10 mM g) essentially as described 28 Peroxidase activity was detected with bioluminescence reagent (ECL kit;
Real-time RT-PCR analysis
Amersham, Braunschweig, Germany) on X-ray film, and CFTR bands were quantitated with the Molecular Imaging System GS-363 (Bio-Rad).
CFTR antibody
The rabbit polyclonal antibody R3195 (kindly donated by Dr. Christopher 
Immunocytochemical analysis
Wild-type mice and littermate mice carrying the G480C mutation were sacrificed by cervical dislocation, the intestine was dissected and the jejunum was rinsed with ice-cold saline and fixed in 3% (wt/vol) paraformaldehyde for 16
h, prior to standard paraffin embedding. Sections (5-µm) were deparaffinized, followed by microwave treatment in 0.01M sodium citrate solution according to 29 .
Endogenous Bioelectric characteristics of A) caecum, B) jejunum and C) nose of wildtype (black bars) and G480C Cftr tm2Hgu homozygous mutant mice. **** = p=0.0001; *** = p<0.001; ** = p<0.01; * = p<0.05. There was no significant difference in the tissue conductances in either the caecum or jejunum from wild type or mutant animals.
Numbers of animals used, jejunum and caecum baselines and forskolin responses: G480C 12, littermate controls 11, carbachol responses: G480C 6, littermate controls 7; nose baseline: G480C 13, controls 45, nose low chloride:
G480C 16, control 38.
Table 1
Results from ileum, jejunum and testis show no evidence of an allele bias, only small and inconsistent fluctuations around a 1:1 ratio. Repetitions indicated by the bracketed numbers represent a repetition of the PCR reaction, using the same cDNA stock. 
